Flex Pharma, founded by serial biotech entrepreneur Christoph Westphal, is lining up for an IPO less than a year after its launch, angling to raise $60 million to bankroll its work in muscle disorders.

…read more

Source: Westphal’s Flex Pharma swings for a quick $60M IPO